Biocon Ltd, an innovation-led global biopharmaceutical company, has been ranked 13th among the world’s top 20 employers in biotechnology, biopharmaceutical, pharmaceutical and related industries in the 2026 survey conducted by US-based science journal Science.
The recognition reinforces Biocon’s position as an employer of choice in the global life sciences industry. The company has featured consistently in the Science Careers Top Employers list since making its debut in 2012.
Recognition for workplace culture
In the 2026 survey, Biocon was recognised for three attributes: social responsibility, respect for employees and a workplace culture aligned with employee values.
The company said its people-centric culture remains central to strengthening its employer brand and supporting its ambition to become a fully integrated global medicines company.
Management comment
“This recognition reflects the talent, passion and commitment of our people. As we advance our ambition to become a fully integrated global medicines company, we remain committed to fostering a culture of innovation, excellence and collaboration, enabling us to make a meaningful difference to patients worldwide,” Biocon, CEO and Managing Director, Shreehas Tambe, said.
Global workforce spans 37 nationalities
Biocon’s workforce comprises employees representing 37 nationalities across more than 60 cities worldwide. The company said this diversity brings a range of perspectives and expertise to its mission of developing and delivering medicines to patients globally.
The recognition comes as the company continues to focus on innovation, collaboration and employee engagement across its international operations.
Survey covers 24 employer attributes
The Science and Science Careers 2026 Top Employers Survey assessed companies across 24 characteristics, covering corporate image, financial strength, leadership and direction, and work culture and environment.
The findings were based on approximately 5,100 completed surveys of employees working in biotechnology, biopharmaceutical, pharmaceutical and related industries. Participants rated companies through a web-based survey.
An independent research firm commissioned by the Science/AAAS Office of Publishing conducted the study. The responses were analysed by US-based The Brighton Consulting Group.
North America accounts for most responses
North America accounted for 71% of survey participants, followed by Europe at 19% and Asia-Pacific at 6%.
The survey is conducted by the American Association for the Advancement of Science (AAAS), the publisher of Science and one of the world’s largest general scientific societies.